Similar articles

• Phase I study of immunotherapy of malignant melanoma by direct gene transfer.

  Hersh EM, Akporiaye E, Harris D, Stopeck AT, Unger EC, Warneke JA, Kradjian SA. Hersh EM, et al. Hum Gene Ther. 1994 Nov;5(11):1371-84. doi: 10.1089/hum.1994.5.11-1371. Hum Gene Ther. 1994. PMID: 7893808 Clinical Trial. No abstract available.
• Direct transfer of a foreign MHC gene into human melanoma alters T cell receptor V beta usage by tumor-infiltrating lymphocytes.

  DeBruyne LA, Chang AE, Cameron MJ, Yang Z, Gordon D, Nabel EG, Nabel GJ, Bishop DK. DeBruyne LA, et al. Cancer Immunol Immunother. 1996 Sep;43(1):49-58. doi: 10.1007/s002620050303. Cancer Immunol Immunother. 1996. PMID: 8917636
• Immune response in human melanoma after transfer of an allogeneic class I major histocompatibility complex gene with DNA-liposome complexes.

  Nabel GJ, Gordon D, Bishop DK, Nickoloff BJ, Yang ZY, Aruga A, Cameron MJ, Nabel EG, Chang AE. Nabel GJ, et al. Proc Natl Acad Sci U S A. 1996 Dec 24;93(26):15388-93. doi: 10.1073/pnas.93.26.15388. Proc Natl Acad Sci U S A. 1996. PMID: 8986821 Free PMC article. Clinical Trial.
• Direct gene transfer for treatment of human cancer.

  Nabel GJ, Yang ZY, Nabel EG, Bishop K, Marquet M, Felgner PL, Gordon D, Chang AE. Nabel GJ, et al. Ann N Y Acad Sci. 1995 Nov 27;772:227-31. doi: 10.1111/j.1749-6632.1995.tb44748.x. Ann N Y Acad Sci. 1995. PMID: 8546397 Review.
• Is antigen specificity the key to efficient adoptive T-cell therapy?

  Labarriere N, Khammari A, Lang F, Dreno B. Labarriere N, et al. Immunotherapy. 2011 Apr;3(4):495-505. doi: 10.2217/imt.11.16. Immunotherapy. 2011. PMID: 21463191 Review.